Saturday 17 October 2026
Export TECX’s income statement to Excel — free account
Tectonic Therapeutic, Inc.
TECX Healthcare Biotechnology
In the quarter to June 2026, EPS fell 10.3%, free cash flow fell 46.7% and total debt fell 94.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
20.65
0.65
−3.05%
Follow TECX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
26.63 | 12.65 | 0.76 | 7.62 | 10.27 | 16.09 | 13.96 | 12.26 | 2.40 | 6.03 |
Net Debt/EBITDA |
3.08 | 2.50 | 0.65 | 0.75 | 1.49 | 2.18 | 2.50 | 2.76 | 0.33 | 1.16 |
Debt/Assets |
0.02% | 0.25% | 2.22% | 14.70% | 7.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (0.01) | 0.20 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.81 | 1.02 | 0.95 | 0.92 | 0.82 | 0.83 | 0.93 | 0.77 | 0.87 | 0.67 |
Capex/Depreciation |
(0.10) | (0.09) | (0.19) | (0.19) | (1.76) | (0.98) | (1.86) | (4.39) | (5.55) | — |
Interest Coverage |
(1,333.90) | (542.20) | (293.74) | — | — | (167.22) | (25.84) | (26.79) | (322.56) | (770.83) |
| (37.82%) | (206.56%) | 924.30% | (86.50%) | (56.22%) | (54.37%) | (47.35%) | (98.14%) | 135.19% | 35.86% | |
| (35.83%) | (60.30%) | (59.75%) | (68.81%) | (50.15%) | (50.75%) | (43.69%) | (69.19%) | (301.61%) | (80.00%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(29.79%) | (42.20%) | 622.25% | (118.00%) | (64.78%) | (47.19%) | (39.36%) | (39.82%) | (464.61%) | (110.79%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(3.29) | (6.98) | (32.28) | (2.23) | (2.34) | (2.76) | (2.52) | (2.94) | (7.50) | (1.63) |
Cash per Share |
13.88 | 16.64 | 22.67 | 2.12 | 4.42 | 7.17 | 6.82 | 9.40 | 2.67 | 2.63 |
Shareholders Equity per Share |
13.72 | 16.58 | (66.69) | 1.72 | 3.95 | 7.02 | 6.78 | 9.09 | (10.35) | (2.25) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.72 | 16.58 | (66.69) | 1.72 | 3.95 | 7.02 | 6.78 | 9.09 | (10.35) | (2.25) |
Free Cash Flow |
(60.22) | (59.24) | (40.96) | (97.47) | (100.49) | (99.98) | (69.25) | (39.48) | (16.76) | (3.31) |
Working Capital |
247.69 | 135.25 | (10.00) | 86.84 | 179.76 | 250.63 | 181.68 | 119.41 | 3.68 | 4.49 |
Capital Expenditures |
(0.14) | (0.16) | (0.28) | (0.27) | (2.46) | (1.18) | (1.58) | (1.83) | (0.38) | — |
Net Current Asset Value |
247.65 | 134.73 | (93.15) | 71.38 | 164.78 | 250.35 | 181.20 | 118.73 | (23.85) | (4.60) |
| Other line items | ||||||||||
Quick Ratio |
26.32 | 12.17 | 0.70 | 7.08 | 9.78 | 15.63 | 13.34 | 11.91 | 2.27 | 6.01 |
Depreciation/Fixed assets |
1.16 | 0.76 | 0.47 | 0.50 | 0.34 | 0.39 | 0.23 | 0.16 | 0.20 | — |
Cash ROIC |
(11.91%) | (20.98%) | 74.48% | (53.12%) | (26.87%) | (19.45%) | (18.56%) | (15.89%) | 97.63% | (425.96%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(3.28) | (6.96) | (32.06) | (2.22) | (2.29) | (2.73) | (2.47) | (2.80) | (7.33) | (1.63) |
Capex per Share |
(0.01) | (0.02) | (0.22) | (0.01) | (0.06) | (0.03) | (0.06) | (0.14) | (0.17) | 0.00 |
Average Receivables |
— | — | — | 1.48 | 2.63 | 2.35 | 1.84 | 1.84 | — | — |
Average Payables |
1.03 | 0.69 | 0.40 | 1.94 | 3.08 | 3.32 | 3.37 | 1.66 | 0.43 | 0.43 |
Average Assets |
206.97 | 96.15 | 71.67 | 153.89 | 237.54 | 235.87 | 167.00 | 70.25 | 6.21 | 6.21 |
Average Common Equity |
196.05 | 28.07 | (4.63) | 122.42 | 211.91 | 220.18 | 154.10 | 49.52 | (13.86) | (13.86) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Columns are period end dates